Accessibility Menu
iTonic Stock Quote

iTonic (NASDAQ: PTHL)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
N/A
Daily Change
N/A
Day's Range
N/A
Previous Close
N/A
Open
N/A
Beta
N/A
Volume
N/A
Average Volume
N/A
Market Cap
N/A
Market Cap / Employee
N/A
52wk Range
N/A
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
N/A
CAPs Rating
N/A
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

iTonic Company Info

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.

News & Analysis

No results found

No news articles found for iTonic.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.